New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
05:55 EDTAVEO, AVEO, CAH, CAH, ABC, ABC, AET, AET, CVS, CVS, BMY, BMY, JPM, JPM, MCK, MCK, CLSN, CLSNCBI to host a forum
6th Annual Forum on Oncology Market Access & Payer Strategies is being held in Philadelphia on January 30-31.
News For MCK;CLSN;AVEO;CAH;ABC;AET;CVS;BMY;JPM From The Last 14 Days
Check below for free stories on MCK;CLSN;AVEO;CAH;ABC;AET;CVS;BMY;JPM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 15, 2014
07:01 EDTJPMJPMorgan reports Q2 adjusted EPS $1.46, consensus $1.29
Subscribe for More Information
06:19 EDTJPMJPMorgan reports June net charge losses 2.84% vs. 3.05% last month
Subscribe for More Information
July 14, 2014
16:23 EDTCVSCVS Caremark acquires Miami-based Navarro Discount Pharmacy
Subscribe for More Information
15:24 EDTJPMNotable companies reporting before tomorrow's open
Subscribe for More Information
14:40 EDTJPMJPMorgan July 56.5 straddle priced for 2.2% move into Q2
Subscribe for More Information
08:01 EDTJPMJP Morgan July volatility increases into Q2 and outlook
Subscribe for More Information
July 11, 2014
07:20 EDTJPMBig banks seen losing reserve release cushion, Reuters says
Releasing loan-loss reserves has helped U.S. big banks weather a period of weak loan demand and lower fee income, but Q2 results from the banks may see less benefit from the practice as loss rates and reserves near their lower limits, said Reuters. Publicly traded companies in the space include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
July 10, 2014
12:43 EDTBMYBristol-Myers announces plans for Q3 submission of Opdivo BLA
Bristol-Myers Squibb announced earlier that, following discussions with the FDA, the company is planning a Q3 submission of a Biologics Licensing Application for Opdivo for previously treated advanced melanoma. This will mark the second tumor type for which Bristol-Myers Squibb has a regulatory submission underway for Opdivo in the U.S. “We continue to collaborate closely with the FDA on Opdivo and the planned submission in advanced melanoma represents an important step forward in our company’s commitment to deliver innovative treatment options for patients with cancer,” said Michael Giordano, MD, Head of Oncology Development, Bristol-Myers Squibb. The advanced melanoma BLA is based on data from Checkmate -037, a multinational, multicenter, randomized open-label Phase 3 trial evaluating Opdivo compared to dacarbazine or carboplatin/paclitaxel in patients with unresectable or metastatic melanoma who have been previously treated with Yervoy and, if BRAF-mutation positive, a BRAF inhibitor regimen. Bristol-Myers Squibb has proposed the name Opdivo, which, if approved by health authorities, will serve as the trade name for nivolumab.
08:03 EDTMCKAccretive Health names Emad Rizk as CEO and president
Accretive Health (ACHI) announced that its Board of Directors has appointed Emad Rizk, M.D., president of McKesson Health Solutions (MCK), as CEO, President, and a member of the Board of Directors, effective July 21.
07:11 EDTAETAetna, WellPoint top large-cap Managed Care picks at Jefferies
Jefferies calls Aetna (AET) and WellPoint (WLP) its favorite large-cap picks in the Managed Care space, with Health Net (HNT) its favored name in the small to mid-cap space. The firm believes the market is already expecting strong Q2 results from the sector, and it downgraded UnitedHealth (UNH) to Hold from Buy on valuation and below-peer earnings growth. Jefferies has Buy ratings on Aetna, Health Net, Molina Healthcare (MOH) and WellPoint.
06:23 EDTAETHealth insurers moving away from fee for service model, NY Times reports
Subscribe for More Information
06:21 EDTJPMJPMorgan appoints Li as new China head, Reuters says
JPMorgan Chase (JPM) said it has appointed former UBS (UBS) banker David Li as the new head of its China division to replace top China banker Fang Fang who left the firm in March, according to Reuters, citing a statement from the U.S. company. Reference Link
July 9, 2014
12:56 EDTAETAetna names Harold L. Paz, M.D., M.S. as Chief Medical Officer
Subscribe for More Information
July 8, 2014
13:39 EDTJPMJPMorgan seeks hundreds of millions in annual expense cuts, WSJ reports
Subscribe for More Information
13:39 EDTJPMJP Morgan names Blessing as Vice Chair of IB EMEA, Bloomberg reports
Subscribe for More Information
13:19 EDTJPMJP Morgan July volatility increases into Q2 and outlook
JP Morgan July call option implied volatility is at 19, August is at 17, October is at 16; compared to its 26-week average of 18 according to Track Data, suggesting large price movement into the expected release of Q2 results on July 15.
13:13 EDTJPMJPMorgan plans hundreds of millions in expense cuts this year, Dow reports
JPMorgan plans hundreds of millions of dollars in expense savings this year via office locations, third-party contracts and market data cuts, Dow Jones reports, citing sources.
12:58 EDTJPMBlackRock poaches JPMorgan Asset Management's Chris Jones, Reuters reports
BlackRock (BLK) has hired Chris Jones, an adviser from JPMorgan Asset Management (JPM), Reuters reports. Jones will serve as co-head of BlackRock's Global Fundamental Equity. Reference Link
07:20 EDTBMYBristol-Myers price target lowered to $55 from $62 at Leerink
Subscribe for More Information
07:17 EDTBMYLeerink raises immuno-oncology market forecast to $36B
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use